-
New study adds to growing evidence that acetaminophen use during pregnancy linked with increased autism, ADHD risks.
-
-
A federal judge has granted summary judgment in Tylenol ADHD lawsuits, dismissing them due to a lack of expert witnesses who can prove to juries that acetaminophen use during pregnancy causes developmental disorders.
-
Drug safety organization indicates that a Hikma Acetaminophen IV bag recall is forthcoming, after at least one patient was accidentally given the wrong IV solution due to a labeling mix-up.
-
A federal judge has again rejected expert testimony that could have linked prenatal use of acetaminophen to an increased risk of ADHD and autism, leaving plaintiffs without a way to prove a causal connection to juries.
-
The FDA is proposing new label warnings for products containing acetaminophen, due to the risk of potentially fatal skin reactions.
-
A federal judge is allowing some recently-filed Tylenol ADHD lawsuits to potentially proceed, using new expert testimony that was not rejected in a decision which virtually ended the litigation late last year.
-
A federal judge has issued a final judgment dismissing hundreds of Tylenol autism and ADHD lawsuits claiming acetaminophen use during pregnancy caused developmental disorders in their children.
-
The FDA is reminding consumers not to exceed 4,000 mg of acetaminophen, which is used in hundreds of cold, flu and pain medications, due to the risks of acetaminophen overdose and liver damage.
-
A federal judge has dismissed expert witnesses who were expected to testify that Tylenol use during pregnancy can cause autism and ADHD.